Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial : Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial).
Longo de Oliveira ALM, de Oliveira Pereira RF, Agati LB, Ribeiro CM, Kawamura Suguiura GY, Cioni CH, Bermudez M, Pirani MB, Caffaro RA, Castelli V Jr, Resende Aguiar VC, Volpiani GG, Paschoa A, Scarlatelli Macedo AV, de Barros E Silva PGM, de Campos Guerra JC, Fareed J, Lopes RD, Ramacciotti E.
Longo de Oliveira ALM, et al. Among authors: fareed j.
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221132556. doi: 10.1177/10760296221132556.
Clin Appl Thromb Hemost. 2022.
PMID: 36474344
Free PMC article.
Clinical Trial.